Home › Edema › NCT07834710

Using Bioimpedance Analysis to Monitor Fluid Status in Children

Using Bioimpedance Analysis to Monitor Fluid Status in Children Undergoing Stem Cell Transplantation

Who can join

Ages 6 to 21 · All sexes

Inclusion Criteria:

* Ages 6-21 years planned to undergo allogeneic or autologous HSCT for any indication with any preparative regimen.

Exclusion Criteria:

* Pacemaker implantation due to incompatibility with the bioimpedance device
* Lack of agreement from the primary HSCT physician.
* Inability or unwillingness of the research participant and/or legal guardian/representative to provide written informed consent.

About the study

This study aims to develop a more comprehensive approach to monitoring fluid status in patients undergoing stem cell transplantation by combining conventional methods with a bioimpedance device.

What is being tested

• Bioimpedance device (diagnostic test)

Sponsor: St. Jude Children's Research Hospital · Participants: 30 · Started: Nov 5, 2026

Contact the study team

• Ghafoor Ghafoor, MD · Phone: 888-226-4343

Official record on ClinicalTrials.gov — NCT07834710

Locations in the U.S.

Conditions

• Edema

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.